Patents by Inventor Stephen Soukasene

Stephen Soukasene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Encapsulated peptide amphiphile nanostructures
    Patent number: 8080262
    Abstract: The present invention provides compositions and methods for creating encapsulated peptide amphiphilic nanostructures useful in treating diseases. In particular, the present invention provides compositions and methods for preparing peptide amphiphile nanostructures that are encapsulated in liposomes by the application of light, and using such compositions in treating diseases, such as cancer.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: December 20, 2011
    Assignee: Northwestern University
    Inventors: Hyung-Kun Lee, Stephen Soukasene, Samuel I. Stupp
  • Encapsulated Peptide Amphiphile Nanostructures
    Publication number: 20100172961
    Abstract: The present invention provides compositions and methods for creating encapsulated peptide amphiphilic nanostructures useful in treating diseases. In particular, the present invention provides compositions and methods for preparing peptide amphiphile nanostructures that are encapsulated in liposomes by the application of light, and using such compositions in treating diseases, such as cancer.
    Type: Application
    Filed: October 24, 2007
    Publication date: July 8, 2010
    Applicant: Northwestern University
    Inventors: Hyung-Kun Lee, Stephen Soukasene, Samuel I. Stupp
  • Solvates and polymorphs of ritonavir and methods of making and using the same
    Patent number: 7205413
    Abstract: Novel solvates and crystal polymorphs of Ritonavir are disclosed, as well as methods of making them. Specific solvates of the compound include a formamide solvate and a partially desolvated solvate. Also disclosed are methods of making previously known forms of Ritonavir. Methods of using the novel forms of Ritonavir for the treatment of diseases, such as HIV-infection, are disclosed, as are pharmaceutical compositions and unit dosage forms comprising the novel forms of Ritonavir.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: April 17, 2007
    Assignee: TransForm Pharmaceuticals, Inc.
    Inventors: Sherry L. Morissette, Orn Almarsson, Stephen Soukasene
  • Solvates and polymorphs of ritonavir and methods of making and using the same
    Publication number: 20040024031
    Abstract: Novel solvates and crystal polymorphs of Ritonavir are disclosed, as well as methods of making them. Specific solvates of the compound include a formamide solvate and a partially desolvated solvate. Also disclosed are methods of making previously known forms of Ritonavir. Methods of using the novel forms of Ritonavir for the treatment of diseases, such as HIV-infection, are disclosed, as are pharmaceutical compositions and unit dosage forms comprising the novel forms of Ritonavir.
    Type: Application
    Filed: May 1, 2003
    Publication date: February 5, 2004
    Applicant: Transform Pharmaceuticals, Inc.
    Inventors: Sherry L. Morissette, Orn Almarsson, Stephen Soukasene